Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Legacy Ranch #2
WARNING LETTER
•Legacy Ranch #2•October 8, 2015

FDA WARNING_LETTER - Legacy Ranch #2 - October 08, 2015

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Legacy Ranch #2
Record Details

On September 30 and October 08, 2015, the FDA inspected Legacy Ranch #2, a dairy operation in Pixley, California. The inspection revealed violations of the Federal Food, Drug, and Cosmetic Act (FD&C Act) related to the extralabel use of the new animal drug (b)(4) (sterile penicillin G procaine, injectable suspension).

Specifically, Legacy Ranch #2 administered (b)(4) to dairy cows without adhering to the dosage per injection site and withdrawal period specified in the veterinarian's label directions. This constituted an extralabel use of the drug, which is only permissible under the FD&C Act if it complies with sections 512(a)(4) and (5) and 21 C.F.R. Part 530, including being by or on the lawful order of a licensed veterinarian within a valid veterinarian/client/patient relationship. The FDA found that the extralabel use of (b)(4) was not under the supervision of a licensed veterinarian, violating 21 C.F.R. 530.11(a).

This non-conformance with approved labeling and 21 C.F.R. Part 530 caused the drug to be unsafe under section 512(a) of the FD&C Act and adulterated under section 501(a)(5). Legacy Ranch #2 is

Company
Legacy Ranch #2
Inspection Date
October 8, 2015
Product Type
Drugs
Office
San Francisco District Office
Person
  • Kathleen M. Lewis
Open in Dashboard

ID · 983b1985-f493-4d45-8b5c-d5369ee366c7

Violation Codes7
21 CFR 530.3(a)21 U.S.C. 360b(a)(4)21 U.S.C. 360b(a)(5)21 CFR 53021 CFR 530.11(a)21 U.S.C. 360b(a)21 U.S.C. 351(a)(5)

Full citation text and observation details available on the Dashboard.

KeyPedia
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.